Eni and Dompe farmaceutici join forces for health research
Eni will guarantee Dompé researchers access to its laboratories, support from the company's specialized staff, and use of its HPC5 supercomputer
Eni will guarantee Dompé researchers access to its laboratories, support from the company's specialized staff, and use of its HPC5 supercomputer
Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge
Alignment of carbon-fiber can be controlled during the 3D printing process
The company had submitted a comprehensive Corrective and Preventive Action (CAPA) plan in September 2022
Increased capability to produce medicines for challenging diseases including cancer
Advances Amgen's mission to serve patients with rare disease medicines
The Main campaign started from October 2
The sale/transfer of the Company's API NonAntibiotic Business and API Antibiotic Business to Apitoria are complete
Subscribe To Our Newsletter & Stay Updated